Alector Inc.

This study looked at the long-term safety of an experimental drug called AL002 in 197 people with early Alzheimer's disease. The goal was to see how safe and tolerable the drug was over time, including checking for side effects like brain swelling or bleeding. The study was termi…

This study aimed to give continued access to the experimental drug latozinemab for people with neurodegenerative diseases who had already taken it in a previous study. Only 17 participants were enrolled before the study was terminated early. The main goals were to track how long …

This study tested an experimental drug called AL001 in people who have a specific gene mutation that puts them at risk for or already causes frontotemporal dementia (FTD). The goal was to see if the drug could slow down the disease. The study was stopped early, so results are lim…